Wendy Yarno Buys Shares of TARS
Wendy Yarno made a significant insider purchase of TARS shares on June 12, 2026.
Key Points
- Wendy Yarno bought 2,954 shares of TARS on June 12, 2026, as part of an insider transaction.
- TARS shares are trading at $61.85, with positive analyst ratings and a robust market presence.
- Deep Track Capital increased its TARS holdings by 595,966 shares, while BlackRock reduced its position by 237,945 shares.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Wendy Yarno, a notable insider, purchased 2,954 shares of TARS on June 12, 2026. This move comes amidst other insider transactions and reflects ongoing interest in the company's stock.
Insider Buying and Selling at Tarsus Pharmaceuticals, Inc.
On June 12, 2026, Wendy Yarno bought 2,954 shares of TARS. This transaction was not part of a pre-arranged trading plan. Other insiders, including William Link, also acquired shares, while several insiders, like Bhaskar Chaudhuri and Scott Morrison, sold the same number of shares.
Other Institutional Activity in TARS
Deep Track Capital, LP increased its stake in TARS by 595,966 shares, bringing its total to 3,600,000 shares valued at approximately $252.5 million. Meanwhile, BlackRock, Inc. reduced its holdings by 237,945 shares, leaving it with 3,552,612 shares worth about $249.2 million. RTW Investments, LP made a modest addition of 10,705 shares, resulting in a total of 3,346,025 shares valued at $234.7 million. Janus Henderson Group PLC also boosted its position by 310,638 shares to 2,240,963 shares, valued at $157.2 million.
Tarsus Pharmaceuticals, Inc. Stock Down 13.8%
Shares of TARS are currently trading at $61.85. The company has seen various institutional movements, reflecting different levels of confidence among investors. Analyst ratings remain positive, indicating a strong outlook for the stock.
$TARS stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On May 4, 2026, HC Wainwright & Co. reiterated its buy rating for TARS with a price target of $88. Oppenheimer and Guggenheim both maintained their buy ratings in February 2026, with price targets of $105 and $90, respectively. Barclays and Mizuho initiated buy ratings in late 2025, each setting a target of $100.
Bottom Line
Wendy Yarno's insider purchase signals confidence in TARS, aligning with positive institutional and analyst sentiment. While insider trades can signal various motivations, they offer a glimpse into the stock's potential. Investors often track these activities as part of their broader analysis, though it's important to remember that insider transactions are not immediate buy or sell signals.
Get Tarsus Pharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $TARS, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.